Company | Cap $ | P/E | P/B | P/S | ROE | ROA | ROS | L/A | P/FCF | PR | Period |
---|---|---|---|---|---|---|---|---|---|---|---|
Orthofix Medical | 491 | 2023q1 | |||||||||
Pacific Biosciences of Ca... | 568 | 2022 | |||||||||
Pacira Biosciences | 802 | 2023 | |||||||||
Passage Bio | 63 | 2023q3 | |||||||||
Patterson Companies | 1,864 | 2024q3 | |||||||||
Pediatrix Medical Group | 1,377 | 2024q2 | |||||||||
Penumbra | 7,928 | 2023q3 | |||||||||
Perrigo Company | 3,717 | 2022 | |||||||||
Pfizer | 174,022 | 2023q3 | |||||||||
Pliant Therapeutics | 851 | 2023q3 | |||||||||
Praxis Precision Medicine... | 10,011 | 2023q3 | |||||||||
Precigen | 275 | 2021 | |||||||||
Prelude Therapeutics | 294 | 2023q2 | |||||||||
Premier | 2,352 | 2023q3 | |||||||||
Prestige Consumer Healthc... | 3,565 | 2024q3 | |||||||||
Progyny | 1,598 | 2023 | |||||||||
Prothena | 1,362 | 2022 | |||||||||
PTC Therapeutics, Inc | 3,242 | 2023q3 | |||||||||
Pulmonx | 289 | 2023 | |||||||||
QIAGEN | 9,233 | 2021 |